- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
BiondVax Pharmaceuticals (NASDAQ:BVXV), Quotes and News Summary
BiondVax Pharmaceuticals (NASDAQ: BVXV)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-25 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.200 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
BiondVax Pharmaceuticals Questions & Answers
You can purchase shares of BiondVax Pharmaceuticals (NASDAQ: BVXV) through any online brokerage.
Other companies in BiondVax Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Graybug Vision (NASDAQ:GRAY), Cumberland (NASDAQ:CPIX), Onconova Therapeutics (NASDAQ:ONTX) and Akanda (NASDAQ:AKAN).
The latest price target for BiondVax Pharmaceuticals (NASDAQ: BVXV) was reported by Aegis Capital on Wednesday, January 26, 2022. The analyst firm set a price target for 7.00 expecting BVXV to rise to within 12 months (a possible 483.33% upside). 1 analyst firms have reported ratings in the last year.
The stock price for BiondVax Pharmaceuticals (NASDAQ: BVXV) is $1.2 last updated Today at June 27, 2022, 4:41 PM UTC.
There are no upcoming dividends for BiondVax Pharmaceuticals.
BiondVax Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 25, 2022.
There is no upcoming split for BiondVax Pharmaceuticals.
BiondVax Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.